Adipose-derived protein omentin prevents neointimal formation after arterial injury

FASEB Journal

Volumn 29, Issue 1, 2015, Pages 141-151

  Uemura, Yusuke ^a   Shibata, Rei ^a   Kanemura, Noriyoshi ^a   Ohashi, Koji ^a   Kambara, Takahiro ^a   Hiramatsu Ito, Mizuho ^a   Enomoto, Takashi ^a   Yuasa, Daisuke ^a   Joki, Yusuke ^a   Matsuo, Kazuhiro ^a   Ito, Masanori ^a   Hayakawa, Satoko ^a   Ogawa, Hayato ^a   Murohara, Toyoaki ^a   Ouchi, Noriyuki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AMPK; Remodeling; VSMC

Indexed keywords

ADENOVIRUS VECTOR; ADIPOCYTOKINE; ARGINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; MESSENGER RNA; MGL 1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OMENTIN PROTEIN; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ITLN1 PROTEIN, HUMAN; LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOINTIMA; NONHUMAN; OBESITY; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR REMODELING; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CELL MOTION; DISEASE MODEL; FEMORAL ARTERY; GENETICS; INJURIES; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE;

MUS;

ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMORAL ARTERY; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; VASCULAR REMODELING;

EID: 84922748573     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-258129     Document Type: Article

References (34)

1. Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., Fox, C. S., Fullerton, H. J., Gillespie, C., Greenlund, K. J., Hailpern, S. M., Heit, J. A., Ho, P. M., Howard, V. J., Kissela, B. M., Kittner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Makuc, D. M., Marcus, G. M., Marelli, A., Matchar, D. B., McDermott, M. M., Meigs, J. B., Moy, C. S., Mozaffarian, D., Mussolino, M. E., Nichol, G., Paynter, N. P., Rosamond, W. D., Sorlie, P. D., Stafford, R. S., Turan, T. N., Turner, M. B., Wong, N. D., Wylie-Rosett, J.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2011) Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 123, e18-e209
2. Erlinge, D. (1998) Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen. Pharmacol. 31, 1-8
3. Matsuzawa, Y. (2006) Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 3, 35-42
4. Després, J. P., and Lemieux, I. (2006) Abdominal obesity and metabolic syndrome. Nature 444, 881-887
5. Nielsen, S., and Jensen, M. D. (1997) Obesity and cardiovascular disease: is body structure a factor? Curr. Opin. Lipidol. 8, 200-204
6. Ouchi, N., Parker, J. L., Lugus, J. J., and Walsh, K. (2011) Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97
7. Yang, R. Z., Lee, M. J., Hu, H., Pray, J., Wu, H. B., Hansen, B. C., Shuldiner, A. R., Fried, S. K., McLenithan, J. C., and Gong, D. W. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 290, E1253-E1261
8. Tsuji, S., Uehori, J., Matsumoto, M., Suzuki, Y., Matsuhisa, A., Toyoshima, K., and Seya, T. (2001) Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J. Biol. Chem. 276, 23456-23463
9. de Souza Batista, C. M., Yang, R. Z., Lee, M. J., Glynn, N. M., Yu, D. Z., Pray, J., Ndubuizu, K., Patil, S., Schwartz, A., and Kligman, M., Fried, S. K., Gong, D. W., Shuldiner, A. R., Pollin, T. I., McLenithan, J. C. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56, 1655-1661
10. Shibata, R., Ouchi, N., Takahashi, R., Terakura, Y., Ohashi, K., Ikeda, N., Higuchi, A., Terasaki, H., Kihara, S., and Murohara, T. (2012) Omentin as a novel biomarker of metabolic risk factors. Diabetol. Metab. Syndr. 4, 37
11. Pan, H. Y., Guo, L., and Li, Q. (2010) Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res. Clin. Pract. 88, 29-33
12. Shibata, R., Takahashi, R., Kataoka, Y., Ohashi, K., Ikeda, N., Kihara, S., Murohara, T., and Ouchi, N. (2011) Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens. Res. 34, 1309-1312
13. Yoo, H. J., Hwang, S. Y., Hong, H. C., Choi, H. Y., Yang, S. J., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., Choi, D. S., and Baik, S. H. (2011) Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc. Diabetol. 10, 103
14. Shibata, R., Ouchi, N., Kikuchi, R., Takahashi, R., Takeshita, K., Kataoka, Y., Ohashi, K., Ikeda, N., Kihara, S., and Murohara, T. (2011) Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219, 811-814
15. Zhong, X., Zhang, H. Y., Tan, H., Zhou, Y., Liu, F. L., Chen, F. Q., and Shang, D. Y. (2011) Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol. Sin. 32, 873-878
16. Maruyama, S., Shibata, R., Kikuchi, R., Izumiya, Y., Rokutanda, T., Araki, S., Kataoka, Y., Ohashi, K., Daida, H., and Kihara, S., Ogawa, H., Murohara, T., Ouchi, N. (2012) Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. J. Biol. Chem. 287, 408-417
17. Yamawaki, H., Tsubaki, N., Mukohda, M., Okada, M., and Hara, Y. (2010) Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem. Biophys. Res. Commun. 393, 668-672
18. Kataoka, Y., Shibata, R., Ohashi, K., Kambara, T., Enomoto, T., Uemura, Y., Ogura, Y., Yuasa, D., Matsuo, K., and Nagata, T., Oba, T., Yasukawa, H., Numaguchi, Y., Sone, T., Murohara, T., Ouchi, N. (2014) Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J. Am. Coll. Cardiol. 63, 2722-2233
19. Shibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N., and Walsh, K. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat. Med. 11, 1096-1103
20. Uemura, Y., Shibata, R., Ohashi, K., Enomoto, T., Kambara, T., Yamamoto, T., Ogura, Y., Yuasa, D., Joki, Y., and Matsuo, K., Miyabe, M., Kataoka, Y., Murohara, T., Ouchi, N. (2013) Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J. 27, 25-33
21. Kondo, M., Shibata, R., Miura, R., Shimano, M., Kondo, K., Li, P., Ohashi, T., Kihara, S., Maeda, N., and Walsh, K., Ouchi, N., Murohara, T. (2009) Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthase. J. Biol. Chem. 284, 1718-1724
22. Ohashi, K., Parker, J. L., Ouchi, N., Higuchi, A., Vita, J. A., Gokce, N., Pedersen, A. A., Kalthoff, C., Tullin, S., and Sams, A., Summer, R., Walsh, K. (2010) Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J. Biol. Chem. 285, 6153-6160
23. Gennaro, G., Ménard, C., Michaud, S. E., Deblois, D., and Rivard, A. (2004) Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation 110, 3367-3371
24. Tanner, F. C., Boehm, M., Akyürek, L. M., San, H., Yang, Z. Y., Tashiro, J., Nabel, G. J., and Nabel, E. G. (2000) Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21 (Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 101, 2022-2025
25. Igata, M., Motoshima, H., Tsuruzoe, K., Kojima, K., Matsumura, T., Kondo, T., Taguchi, T., Nakamaru, K., Yano, M., and Kukidome, D., Matsumoto, K., Toyonaga, T., Asano, T., Nishikawa, T., Araki, E. (2005) Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ. Res. 97, 837-844
26. Nagata, D., Takeda, R., Sata, M., Satonaka, H., Suzuki, E., Nagano, T., and Hirata, Y. (2004) AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 110, 444-451
27. Song, P., Wang, S., He, C., Wang, S., Liang, B., Viollet, B., and Zou, M. H. (2011) AMPKa2 deletion exacerbates neointima formation by upregulating Skp2 in vascular smooth muscle cells. Circ. Res. 109, 1230-1239
28. Lu, J., Ji, J., Meng, H., Wang, D., Jiang, B., Liu, L., Randell, E., Adeli, K., and Meng, Q. H. (2013) The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats. Cardiovasc. Diabetol. 12, 58
29. Yamawaki, H., Kuramoto, J., Kameshima, S., Usui, T., Okada, M., and Hara, Y. (2011) Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem. Biophys. Res. Commun. 408, 339-343
30. Shibata, R., Ouchi, N., Ito, M., Kihara, S., Shiojima, I., Pimentel, D. R., Kumada, M., Sato, K., Schiekofer, S., and Ohashi, K., Funahashi, T., Colucci, W. S., Walsh, K. (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat. Med. 10, 1384-1389
31. Miyabe, M., Ohashi, K., Shibata, R., Uemura, Y., Ogura, Y., Yuasa, D., Kambara, T., Kataoka, Y., Yamamoto, T., and Matsuo, K., Joki, Y., Enomoto, T., Hayakawa, S., Hiramatsu-Ito, M., Itom, M., Van Den Hoff, M. J., Walsh, K., Murohara, T., Ouchi, N. (2014) Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury. Cardiovasc. Res. 103, 111-120
32. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Goetz, R., Eliseenkova, A. V., Mohammadi, M., and Kuro-o, M. (2007) BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. USA 104, 7432-7437
33. Komiya, T., Tanigawa, Y., and Hirohashi, S. (1998) Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem. Biophys. Res. Commun. 251, 759-762
34. Tsuji, S., Yamashita, M., Nishiyama, A., Shinohara, T., Li, Z., Myrvik, Q. N., Hoffman, D. R., Henriksen, R. A., and Shibata, Y. (2007) Differential structure and activity between human and mouse intelectin-1: human intelectin-1 is a disulfide-linked trimer, whereas mouse homologue is a monomer. Glycobiology 17, 1045-1051